Alzheimer’s therapy

US Senator Joe Manchin calls for a new FDA Commissioner to replace current (acting) one who “has repeatedly ignored public health concerns and shown a dereliction of duty” over opioids and aducanumab

by

Key Demo­c­rat Manchin Bash­es FDA Leader on Alzheimer’s Approval (Bloomberg):

Sen­a­tor Joe Manchin, a mod­er­ate Demo­c­rat con­sid­ered a cru­cial vote with­in the party’s slim Sen­ate major­i­ty, said Janet Wood­cock, the tem­po­rary head of the Food and Drug Admin­is­tra­tion, should be quick­ly replaced with a per­ma­nent leader.

Manchin blast­ed an FDA deci­sion to approve the con­tro­ver­sial Alzheimer’s ther­a­py Aduhelm despite con­flict­ing evi­dence that the Bio­gen Inc. drug works and an over­whelm­ing­ly neg­a­tive vote against the ther­a­py by agency advis­ers. The FDA rul­ing led three mem­bers of that pan­el to quit in protest… [Read more…] about US Sen­a­tor Joe Manchin calls for a new FDA Com­mis­sion­er to replace cur­rent (act­ing) one who “has repeat­ed­ly ignored pub­lic health con­cerns and shown a dere­lic­tion of duty” over opi­oids and aducanumab